BioSpace News Archive

Imugene Limited, a clinical stage immuno-oncology company, highlighted recent progress across the company’s immuno-oncology portfolio and provided an update on anticipated upcoming milestones.

The company Swiss Advanced Vision has announced the launch of New Features for its Toric Calculator improving the overall calculation experience.

Intego Clinical, a full-service biometrics Clinical Research Organization (CRO) that helps leading life science companies unlock the power of clinical data, has been accepted to provide three presentations and papers at this year’s

OmniGuide™ Holdings and UROTECH® have announced a new partnership to strengthen UROTECH’s technology portfolio for urologists.

Sanofi’s Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on April 30, 2024, the renewal of the terms of office of Rachel Duan and Lise Kingo and the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors.

Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Monday, March 4th, 2024 at 11:10AM Eastern Time

Cogent Biosciences, Inc. (Nasdaq: COGT) today reported positive Part 1b data from the Company’s ongoing SUMMIT trial evaluating bezuclastinib in patients with nonadvanced systemic mastocytosis (NonAdvSM) at the 2024 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) meeting taking place February 23-26, 2024 in Washington, D.C.

Rejuvenate Bio today announced publication of groundbreaking research in the peer-reviewed journal Cellular Reprogramming.

Compass Pathways plc (Nasdaq: CMPS) announced today that it will release financial results for the fourth quarter and year-end 2023 ending December 31, 2023, and provide an update on recent business developments, on February 29, 2024.

Elutia Inc., a company pioneering drug-eluting biomatrix products, announced that it will release its fourth quarter and full year 2023 financial results after market close on Thursday, March 7, 2024.